Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 609)
Posted On: 01/26/2022 6:23:45 AM
Post# of 155765
Posted By: CTMedic
Re: crazyjogger925 #116102
Crazyjogger,

ICU occupancy in greater São Paulo (location of more than half of Leronlimab trials) continues to climb by 2% daily. 72% ICU occupancy, 77% total bed occupancy.

https://www.seade.gov.br/coronavirus/

Admissions of course lag infections, which have nearly doubled (+91%) over the last week.

https://www.worldometers.info/coronavirus/wee...ekly_table

Interim analysis of critical covid trial at 51 patients at 27 days (noted in 10q)

“ In December 2021, Brazil’s ANVISA agreed to modify the Phase 3 trial for critically ill COVID-19 patients to require a total patient enrollment of 126 patients instead of the previously approved 316 patients and allow for interim efficacy analysis after 51 patients have been treated for 27 days.”

Bad times nearly all around for Covid. Record highs in daily cases today in Russia, Poland, Czechia, Austria and Japan (so far).

As always, Cytodyn needs to show the data. Regulatory approvals will follow.















(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site